Fundraising Fox
/Investor DB
Sign in

BioBrit — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Tocagentocagen.comJul 2023

Tocagen is a clinical-stage biotechnology company developing cancer-selective gene therapies designed to activate a patient's immune system against their own cancer.

BiotechHealthtechSan Diego, US

Harry Gruber(Executive Officer, Director)Thomas Darcy(Executive Officer, Director)Dennis Berman(Executive Officer, Director)Douglas Jolly(Executive Officer)

BoardFaheem Hasnain(Director)Lori Kunkel(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.